Genentech Owns a Patent on Tissue Plasminogen Activator (TPA), Which

question 128

Essay

Genentech owns a patent on tissue plasminogen activator (TPA), which is an enzyme that helps the body break down blood clots. TPA is particularly valuable to cardiac patients, since it often allows heart problems to be treated with medication rather than surgery. Recently, however, firms in the medical industry have come under fire from some members of Congress and the press for charging high prices and earning monopoly profits. Do you think cardiac patients would benefit if the government stripped Genentech and other pharmaceutical firms of their patents? Explain.

---

Definitions:

Transformational Leadership

A leadership style that inspires and motivates employees to exceed expectations by fostering significant change and personal development.

Reengineering

A process that involves the fundamental rethinking and radical redesign of business processes to achieve dramatic improvements in critical measures of performance such as cost, quality, service, and speed.

Survey Feedback

A method of gathering information and insights from respondents about a particular subject, which is then used for analysis, decision-making, or measuring satisfaction and performance.

Change Agents

Individuals or entities that act as catalysts for change, influencing or facilitating improvements or transformations within an organization or community.